Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/s0140-6736(74)90721-1 | DOI Listing |
Int J Dermatol
January 2025
Department of Dermatology, San Cecilio University Hospital, Granada, Spain.
Lung Cancer
December 2024
Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan. Electronic address:
Medicine (Baltimore)
November 2024
Department of Pharmacy, Yaan People's Hospital, Yaan, China.
Background: The combination of methimazole and propranolol is considered an effective treatment regimen for hyperthyroidism in clinical practice; however, detrimental effects on the heart rate, bone metabolism and thyroid hormone levels have been reported. Therefore, the present study aimed to systematically review the efficacy and safety differences in patients with hyperthyroidism and the effects of treatment on heart rate, bone metabolism, cortisol, and adrenocorticotropic hormone levels using case-control studies.
Methods: Clinical case-control trials of methimazole combined with propranolol for the treatment of hyperthyroidism were selected from Chinese and English databases, and data were collected from the establishment of the database until August 2024.
Int J Dermatol
August 2024
Department of Dermatology and Venereology, All India Institute of Medical Sciences, New Delhi, India.
Cutis
June 2024
Drs. Uwakwe and Glick are from and Dr. Buethe was from the Department of Dermatology, SUNY Downstate Health Sciences University, Brooklyn, New York. Dr. Buethe currently is from the University of California San Diego/Rady Children's Hospital. Dr. Di Franco is from the Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, New York.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!